AstraZeneca Licenses GVK Toxicity Database | GenomeWeb

NEW YORK (GenomeWeb News) – Drug giant AstraZeneca has licensed GVK Biosciences’ Mechanism Based Toxicity Database, the Hyderabad, India-based firm announced today.

The database contains more than 13,000 drug and drug-like compounds, their routes of metabolism, toxic indications, and the numerical values of the measures of toxicity, according to GVK.

The license extends AstraZeneca’s existing license for all of GVK’s target and drug databases. Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.